Calidi Biotherapeutics Statistics
Total Valuation
CLDI has a market cap or net worth of $7.83 million. The enterprise value is $13.12 million.
| Market Cap | 7.83M |
| Enterprise Value | 13.12M |
Important Dates
The next estimated earnings date is Saturday, May 18, 2024, before market open.
| Earnings Date | May 18, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLDI has 48.96 million shares outstanding. The number of shares has increased by 98.55% in one year.
| Shares Outstanding | 48.96M |
| Shares Change (YoY) | +98.55% |
| Shares Change (QoQ) | +18.01% |
| Owned by Insiders (%) | 47.63% |
| Owned by Institutions (%) | 5.35% |
| Float | 21.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42
| Current Ratio | 0.42 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -248.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$712,585 |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CLDI has paid $16,000 in taxes.
| Income Tax | 16,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.44% in the last 52 weeks. The beta is 0.42, so CLDI's price volatility has been lower than the market average.
| Beta (1Y) | 0.42 |
| 52-Week Price Change | -98.44% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 3.38 |
| Relative Strength Index (RSI) | 31.52 |
| Average Volume (30 Days) | 660,387 |
Short Selling Information
The latest short interest is 55,247, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 55,247 |
| Short Previous Month | 22,839 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.99M |
| Pretax Income | -29.20M |
| Net Income | -29.22M |
| EBITDA | -26.88M |
| EBIT | -28.13M |
| Earnings Per Share (EPS) | -$1.73 |
Balance Sheet
The company has $1.95 million in cash and $7.24 million in debt, giving a net cash position of -$5.29 million or -$0.11 per share.
| Cash & Cash Equivalents | 1.95M |
| Total Debt | 7.24M |
| Net Cash | -5.29M |
| Net Cash Per Share | -$0.11 |
| Equity / Book Value | -8.24M |
| Book Value Per Share | -0.17 |
| Working Capital | -5.93M |
Cash Flow
In the last 12 months, operating cash flow was -$26.98 million and capital expenditures -$585,000, giving a free cash flow of -$27.57 million.
| Operating Cash Flow | -26.98M |
| Capital Expenditures | -585,000 |
| Free Cash Flow | -27.57M |
| FCF Per Share | -$1.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLDI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -98.55% |
| Shareholder Yield | -98.55% |
| Earnings Yield | -372.96% |
| FCF Yield | -351.92% |
Analyst Forecast
The average price target for CLDI is $3.25, which is 1,931.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.25 |
| Price Target Difference | 1,931.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |